You just read:

Ferring Pharmaceuticals: The Scottish Medicines Consortium Approves Use of NOQDIRNA® (oral lyophilisate desmopressin), the First Licensed Treatment for Nocturia due to Idiopathic Nocturnal Polyuria in Adults

News provided by

Ferring Pharmaceuticals

08 Aug, 2017, 13:08 BST